Table 2.
Comparison of levels of immune and angiogenesis factors in stool from PD patients and controls
| PATIENTS | CONTROLS | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Panel | Factor | N | Mean (pg/mg) |
Std Dev | N | Mean (pg/mg) |
Std Dev | p-value |
| Angiogenesis | Flt1 | 156 | 5.020 | 4.272 | 110 | 3.957 | 3.059 | 0.0184 |
| PlGF | 156 | 1.439 | 1.132 | 110 | 1.352 | 0.6687 | 0.4328 | |
| Tie2 | 156 | 194.2 | 152.1 | 110 | 181.3 | 103.7 | 0.4112 | |
| VEGF-C | 156 | 117.3 | 108.9 | 110 | 116.7 | 124.4 | 0.9662 | |
| VEGF-D | 156 | 19.49 | 14.50 | 110 | 19.39 | 11.32 | 0.9489 | |
| bFGF | 156 | 0.6937 | 0.5598 | 110 | 0.6165 | 0.4322 | 0.2040 | |
|
| ||||||||
| Chemokine | Eotaxin | 156 | 8.878 | 6.160 | 110 | 8.113 | 5.119 | 0.2697 |
| Eotaxin-3 | 156 | 24.05 | 19.06 | 110 | 22.35 | 20.77 | 0.4877 | |
| IP-10 | 156 | 0.4657 | 0.4559 | 110 | 0.3964 | 0.2818 | 0.1265 | |
| MCP-1 | 156 | 0.3225 | 0.5859 | 110 | 0.2562 | 0.2816 | 0.2195 | |
| MCP-4 | 156 | 4.759 | 3.468 | 110 | 4.214 | 2.508 | 0.1366 | |
| MDC | 156 | 11.56 | 8.549 | 110 | 11.48 | 6.903 | 0.9306 | |
| MIP-1α | 156 | 4.879 | 4.204 | 110 | 4.363 | 3.370 | 0.2673 | |
| MIP-1β | 156 | 2.459 | 2.063 | 110 | 2.236 | 1.832 | 0.3616 | |
| TARC | 156 | 0.7362 | 0.6579 | 110 | 0.7790 | 0.5600 | 0.5781 | |
|
| ||||||||
| Cytokine | IL-12/23 p40 | 156 | 2.634 | 1.779 | 110 | 2.481 | 1.522 | 0.4610 |
| IL-15 | 156 | 0.8354 | 0.6445 | 110 | 0.7519 | 0.6075 | 0.2857 | |
| IL-16 | 156 | 16.34 | 17.50 | 110 | 15.28 | 14.17 | 0.5848 | |
| IL-17A | 156 | 2.955 | 8.555 | 110 | 2.104 | 1.452 | 0.2231 | |
| IL-1α | 156 | 98.99 | 326.8 | 110 | 41.65 | 40.39 | 0.0311 | |
| IL-5 | 156 | 0.7553 | 0.8279 | 110 | 0.7062 | 0.6693 | 0.5926 | |
| IL-7 | 156 | 0.7442 | 0.6159 | 110 | 0.6886 | 0.4264 | 0.3829 | |
| LTA | 155 | 0.4188 | 0.4499 | 110 | 0.4174 | 0.3734 | 0.9778 | |
| VEGF | 155 | 22.36 | 82.51 | 110 | 14.48 | 52.62 | 0.3423 | |
|
| ||||||||
| Proinflammatory | IFNγ | 155 | 11.93 | 27.88 | 110 | 9.68 | 14.49 | 0.3906 |
| IL-10 | 155 | 2.231 | 5.473 | 110 | 1.745 | 2.900 | 0.3487 | |
| IL-13 | 155 | 3.463 | 2.437 | 110 | 3.255 | 1.880 | 0.4305 | |
| IL-1β | 155 | 3.451 | 12.22 | 110 | 1.685 | 2.486 | 0.0810 | |
| IL-2 | 155 | 3.161 | 3.922 | 110 | 2.815 | 2.312 | 0.3664 | |
| IL-4 | 155 | 0.6397 | 0.7944 | 110 | 0.5895 | 0.7576 | 0.6042 | |
| IL-6 | 155 | 3.024 | 6.367 | 110 | 2.660 | 4.818 | 0.5951 | |
| IL-8 | 155 | 41.5 | 149.1 | 110 | 14.0 | 53.5 | 0.0358 | |
| TNF | 155 | 0.7482 | 1.055 | 110 | 0.7787 | 0.9975 | 0.8121 | |
|
| ||||||||
| Vascular Injury | CRP | 155 | 1010 | 2909 | 110 | 547.4 | 1605 | 0.0978 |
| SAA | 155 | 109.1 | 378.7 | 110 | 71.76 | 53.12 | 0.2257 | |
| sICAM-1 | 155 | 19.87 | 44.79 | 110 | 13.22 | 41.83 | 0.2202 | |
| sVCAM-1 | 155 | 22.26 | 22.09 | 110 | 22.61 | 21.50 | 0.8953 | |
Mean protein levels (pg/mg total protein) with standard deviations (Std Dev) in stool homogenates
N = number of measurements for each subject group
Gray shading indicates significant (p<0.05) difference between patients and controls by t-test